High serum leptin is associated with attenuated coronary vasoreactivity

Obesity Research

Volumn 11, Issue 6, 2003, Pages 776-782

  Sundell, Jan ^a,b,d   Huupponen, Risto ^c   Raitakari, Olli T ^a,d   Nuutila, Pirjo ^a,b   Knuuti, Juhani ^a  

^a TURKU PET CENTRE   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c Universität Turku   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adenosine; Leptin; Myocardial blood flow; Obese subjects; Positron emission tomography

Indexed keywords

EID: 12744275441     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.108     Document Type: Article

References (38)

1. Casassus P, Fontbonne A, Thibult N, et al. Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality: the Paris Prospective Study. Arterioscler Thromb. 1992;12:1387-92.
2. Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968-77.
3. Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med. 1985;103:983-8.
4. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease: AHA Nutrition Committee. Circulation. 1998;97:2099-100.
5. McGill HC, Jr., McMahan CA, Herderick EE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105:2712-8.
6. Al Suwaidi J, Higano ST, Holmes DR, Jr., et al. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol. 2001;37:1523-8.
7. Sundell J, Laine H, Luotolahti M, et al. Obesity affects myocardial vasoreactivity and coronary flow response to insulin. Obes Res. 2002;10:617-24.
8. Tanida M, Iwashita S, Ootsuka Y, et al. Leptin injection into white adipose tissue elevates renal sympathetic nerve activity dose-dependently through the afferent nerves pathway in rats. Neurosci Lett. 2000;293:107-10.
9. Rahmouni K, Haynes WG, Mark AL. Cardiovascular and sympathetic effects of leptin. Curr Hypertens Rep. 2002;4:119-25.
10. Vecchione C, Maffei A, Colella S, et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes. 2002;51:168-73.
11. Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes. 1999;48:903-8.
12. Wallace AM, McMahon AD, Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation. 2001;104:3052-6.
13. Stangl K, Cascorbi I, Laule M, et al. Elevated serum leptin in patients with coronary artery disease: no association with the Trp64Arg polymorphism of the beta3-adrenergic receptor. Int J Obes Relat Metab Disord. 2000;24:369-75.
14. Konstantinides S, Schafer K, Loskutoff DJ. The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity. Ann N Y Acad Sci. 2001;947:134-41.
15. Ciccone M, Vettor R, Pannacciulli N, et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord. 2001;25:805-10.
16. Cao R, Brakenhielm E, Wahlestedt C, et al. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA. 2001;98:6390-5.
17. Kimura K, Tsuda K, Baba A, et al. Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem Biophys Res Commun. 2000;273:745-9.
18. Quehenberger P, Exner M, Sunder-Plassmann R, et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res. 2002;90:711-8.
19. Dayanikli F, Grambow D, Muzik O, et al. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 1994;90:808-17.
20. Uren NG, Melin JA, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med. 1994;330:1782-8.
21. Pitkanen OP, Raitakari OT, Ronnemaa T, et al. Influence of cardiovascular risk status on coronary flow reserve in healthy young men. Am J Cardiol. 1997;79:1690-2.
22. Crouzel C, Clark J, Brihaye C, et al. Radiochemistry automation for PET. In: Stöckling G, Pike V, eds. Radiopharmaceuticals for Positron Emission Tomography. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1993, pp. 45-90.
23. Laine H, Raitakari OT, Niinikoski H, et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol. 1998;32:147-53.
24. Iida H, Takahashi A, Tamura Y, et al. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med. 1995;36:78-85.
25. Iida H, Rhodes CG, de Silva R, et al. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med. 1992;33:1669-77.
26. Kadish A, Little R, Sternberg J. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem. 1968;14:116-31.
27. Scheinin M, Karhuvaara S, Ojala-Karlsson P, et al. Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers. Life Sci. 1991;49:75-84.
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
29. Mayhan WG. Endothelium-dependent responses of cerebral arterioles to adenosine 5′-diphosphate. J Vasc Res. 1992;29: 353-8.
30. Wilson RF, Wyche K, Christensen BV, et al. Effects of adenosine on human coronary arterial circulation. Circulation. 1990;82:1595-606.
31. Buus NH, Bottcher M, Hermansen F, et al. Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation. 2001;104:2305-10.
32. Opie LH. The Heart. 3rd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1998.
33. Araujo LI, Lammertsma AA, Rhodes CG, et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation. 1991;83:875-85.
34. Nitzsche EU, Choi Y, Czernin J, et al. Noninvasive quantification of myocardial blood flow in humans: a direct comparison of the [13N]ammonia and the [15O]water techniques. Circulation. 1996;93:2000-6.
35. Pyorala M, Miettinen H, Laakso M, et al. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation. 1998;98:398-404.
36. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest. 1996;98:894-8.
37. Vollenweider P, Randin D, Tappy L, et al. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest. 1994;93:2365-71.
38. Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA. 1986;256:2835-8.